مکتبة رقمیه للعلوم الطبيه
Your cart is empty.
  • Cart
  • Lists
    Your lists Log in to create your own lists
  • Log in to your account
  • Your cookies
  • Search history
  • Advanced search
  • Authority search
  • Tag cloud
  • Library

Log in to your account

  1. Home
  2. Details for: Differential effects of histone deacetylase inhibitors on interleukin-18 gene expression in myeloid cells.
Normal view MARC view ISBD view

Differential effects of histone deacetylase inhibitors on interleukin-18 gene expression in myeloid cells. [electronic resource]

By:
  • Koyama, Noriko
Contributor(s):
  • Koschmieder, Steffen
  • Tyagi, Sandhya
  • Nürnberger, Heike
  • Wagner, Sandra
  • Böcker, U
  • Hoelzer, Dieter
  • Gerhard Ottmann, Oliver
  • Kalina, Uwe
Producer: 20020513Description: 937-43 p. digitalISSN:
  • 0006-291X
Subject(s):
  • Blotting, Northern
  • Blotting, Western
  • Butyrates -- pharmacology
  • Cell Differentiation -- drug effects
  • Cell Division -- drug effects
  • Cell Line
  • Cell Survival -- drug effects
  • Enzyme Inhibitors -- pharmacology
  • Gene Expression -- drug effects
  • Growth Inhibitors -- pharmacology
  • Histone Deacetylase Inhibitors
  • Humans
  • Hydroxamic Acids -- pharmacology
  • Interleukin-18 -- genetics
  • Leukemia, Erythroblastic, Acute -- drug therapy
  • Myeloid Cells -- cytology
  • Promoter Regions, Genetic -- drug effects
  • RNA, Messenger -- metabolism
  • U937 Cells
  • Valproic Acid -- pharmacology
Online resources:
  • Available from publisher's website
In: Biochemical and biophysical research communications vol. 292
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Cancel rating. Average rating: 0.0 (0 votes)
  • Holdings ( 0 )
  • Title notes ( 1 )
  • Comments ( 0 )
No physical items for this record

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

There are no comments on this title.

Log in to your account to post a comment.
Browse results Close
Previous
Back to results
Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 1 Dopamine dysregulation of movement control in L-DOPA-induced dyskinesia.
    by Cenci, M Angela
  • 2 Presynaptic Mechanisms of l-DOPA-Induced Dyskinesia: The Findings, the Debate, and the Therapeutic Implications.
    by Cenci, M Angela
  • 3 Glutamatergic pathways as a target for the treatment of dyskinesias in Parkinson's disease.
    by Cenci, M Angela
  • 4 L-DOPA-induced dyskinesia: cellular mechanisms and approaches to treatment.
    by Cenci, M Angela
  • 5 Post- versus presynaptic plasticity in L-DOPA-induced dyskinesia.
    by Cenci, M Angela
  • 6 Ratings of L-DOPA-induced dyskinesia in the unilateral 6-OHDA lesion model of Parkinson's disease in rats and mice.
    by Cenci, M Angela
  • 7 Dyskinesias and dopamine cell replacement in Parkinson's disease: a clinical perspective.
    by Hagell, Peter
  • 8 Investigating the molecular mechanisms of L-DOPA-induced dyskinesia in the mouse.
    by Francardo, Veronica
  • 9 Preface: The evolving scenario of Parkinson's research.
    by Björklund, Anders
  • 10 Recent Advances in Parkinson’s disease - translational and clinical research.
    by Björklund, Anders
  • 11 Maladaptive striatal plasticity in L-DOPA-induced dyskinesia.
    by Cenci, M Angela
  • 12 Animal models for preclinical Parkinson's research: An update and critical appraisal.
    by Cenci, M Angela
  • 13 Zooming in on the small: the plasticity of striatal dendritic spines in L-DOPA-induced dyskinesia.
    by Fieblinger, Tim
  • 14 On the Effect of Eltoprazine in Dyskinetic Hemiparkinsonian Rats.
    by Carta, Manolo
  • 15 Parkinson disease: Poor results for retinal cell transplants in Parkinson disease.
    by Cenci, M Angela
  • 16 Recent advances in Parkinson's disease: basic research. Preface.
    by Björklund, Anders
  • 17 Rodent models of treatment-induced motor complications in Parkinson's disease.
    by Cenci, M Angela
  • 18 Animal models of l-dopa-induced dyskinesia in Parkinson's disease.
    by Cenci, M Angela
  • 19 Bad news for neuroprotective therapies in PD?
    by Cenci, M Angela
  • 20 Translating scientific advances into disease-modifying therapies for Parkinson's Disease.
    by Cenci, M Angela
Close

Differential effects of histone deacetylase inhibitors on interleukin-18 gene expression in myeloid cells.

APA

Koyama N., Koschmieder S., Tyagi S., Nürnberger H., Wagner S., Böcker U., Hoelzer D., Gerhard Ottmann O. & Kalina U. (20020513). Differential effects of histone deacetylase inhibitors on interleukin-18 gene expression in myeloid cells. : Biochemical and biophysical research communications.

Chicago

Koyama Noriko, Koschmieder Steffen, Tyagi Sandhya, Nürnberger Heike, Wagner Sandra, Böcker U, Hoelzer Dieter, Gerhard Ottmann Oliver and Kalina Uwe. 20020513. Differential effects of histone deacetylase inhibitors on interleukin-18 gene expression in myeloid cells. : Biochemical and biophysical research communications.

Harvard

Koyama N., Koschmieder S., Tyagi S., Nürnberger H., Wagner S., Böcker U., Hoelzer D., Gerhard Ottmann O. and Kalina U. (20020513). Differential effects of histone deacetylase inhibitors on interleukin-18 gene expression in myeloid cells. : Biochemical and biophysical research communications.

MLA

Koyama Noriko, Koschmieder Steffen, Tyagi Sandhya, Nürnberger Heike, Wagner Sandra, Böcker U, Hoelzer Dieter, Gerhard Ottmann Oliver and Kalina Uwe. Differential effects of histone deacetylase inhibitors on interleukin-18 gene expression in myeloid cells. : Biochemical and biophysical research communications. 20020513.

  • Print
  • Cite
  • Add to your cart (remove)
  • Save record
    BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
  • More searches
    Search for this title in:
    Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Visit web site